Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is facing some immediate financial risks due to delayed equipment purchases and supply constraints on their robotic catheter production, but their recent launch of the MAGiC robotic catheter and strong customer feedback indicate potential for future revenue growth in the second half of 2026 and beyond. Despite lower revenue forecasts for 2026, projected revenue and operating losses for the second half of the fiscal year have improved, suggesting a brighter outlook for the company's financial performance. The company also has a strong product portfolio and is expected to establish new programs in the current year, indicating potential for future revenue growth. As a result, the financial analyst has a positive outlook on Stereotaxis' stock.

Bears say

Stereotaxis is facing headwinds in its disposable business due to the winding down of its relationship with JNJ and ongoing manufacturing constraints for its newly approved MAGiC catheter. They are working to remedy these issues and reach production of 500 MAGiC catheters per month by year-end, but this may negatively impact their revenue in the short-term. Additionally, while the company remains confident in its sales pipeline for its new GenesisX system, they have not yet reached their goal of 5 placements by the end of the year. Despite a top-line miss in Q1, the company is still expecting full-year revenue of over $40 million, with a heavier weighting towards the back-half of the year.

Stereotaxis Inc (STXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 4 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Sep 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.